drugset / Trial / NCT06653400

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

NCT06653400

Phase 1 Recruiting 60 enrolled Icahn School of Medicine at Mount Sinai
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.

Timeline

Start
2025-02-27
Primary completion
2026-09-01
Completion
2026-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 2 ml
Subject Ketorolac Other / unclassified 30 mg
Background Lidocaine Other / unclassified 1 %
Background Lidocaine Other / unclassified 20 ml